Kentucky 2023 Regular Session

Kentucky House Bill HB290

Introduced
2/14/23  
Refer
2/14/23  
Refer
2/17/23  
Report Pass
2/23/23  
Engrossed
3/7/23  

Caption

AN ACT relating to controlled substances.

Impact

The bill is designed to address the ongoing issues surrounding prescription drug abuse, particularly concerning opioids. It emphasizes the need for healthcare providers to maintain accurate records and establishes protocols for both initial prescriptions and ongoing patient treatment. By implementing these regulations, HB 290 seeks to standardize approaches to controlled substance management across the state and ensure that patients receive medically appropriate care without unnecessary risk of addiction or misuse.

Summary

House Bill 290 aims to amend existing laws related to the prescribing and dispensing of controlled substances within the state. It introduces mandatory standards for healthcare providers tasked with prescribing these medications and includes protocols intended to curb improper, inappropriate, or illegal prescription practices. The bill mandates that practitioners must adhere to specific procedures before prescribing Schedule II controlled substances, ensuring comprehensive patient histories are documented and that prescribers utilize an electronic monitoring system to track prescriptions, thus fostering a more disciplined approach to pain management and addiction prevention.

Sentiment

The sentiment among legislators regarding HB 290 appears to be supportive, especially given the significant bipartisan votes it received during its passage, indicating a recognition of the bill's necessity in combating the prescription drug crisis. While there are advocates for stronger regulations to protect patient health, some concerns were raised about the potential burdens these restrictions may impose on healthcare providers, particularly in rural areas where access to services can be limited. There was an acknowledgment of the fine balance required between safeguarding public health and ensuring access to necessary medical treatments.

Contention

A notable point of contention surrounding HB 290 was the restriction on the duration and quantity of prescriptions for controlled substances, which some members argued could inadvertently affect patients with legitimate ongoing pain management needs. Furthermore, while the goal of reducing abuse is broadly supported, some stakeholders expressed worries about the increased administrative responsibilities placed on healthcare providers and the feasibility of implementing such stringent records and monitoring processes without adequate support or resources.

Companion Bills

No companion bills found.

Similar Bills

KY HB764

AN ACT relating to the Kentucky All Schedule Prescription Electronic Reporting system.

KY HB389

AN ACT relating to prescription drugs.

KY HB710

AN ACT relating to licensees authorized to prescribe or dispense controlled substances.

KY SB27

AN ACT relating to pharmaceutical manufacturers.

KY HB806

AN ACT relating to pharmaceutical manufacturers.

KY HB321

AN ACT relating to health benefit coverage of chronic pain treatments.

KY HB67

AN ACT relating to health benefit coverage of chronic pain treatments.

KY HB58

AN ACT relating to chronic pain treatments.